Egfl7 promotes tumor escape from immunity
- PMID: 22737620
- PMCID: PMC3382845
- DOI: 10.4161/onci.18964
Egfl7 promotes tumor escape from immunity
Abstract
Egfl7 is an endothelial-specific gene which expression is deregulated in human cancers. We showed that Egfl7 promotes tumor escape from immunity by downregulating the expression of leukocyte adhesion molecules in endothelial cells, thus repressing immune cell extravasation into tumors.
Keywords: adhesion molecules; angiogenesis; endothelium; escape from immunity; extravasation.
Figures
Similar articles
-
Egfl7 promotes tumor escape from immunity by repressing endothelial cell activation.Cancer Res. 2011 Dec 1;71(23):7176-86. doi: 10.1158/0008-5472.CAN-11-1301. Epub 2011 Oct 28. Cancer Res. 2011. PMID: 22037871
-
EGF repeats of epidermal growth factor‑like domain 7 promote endothelial cell activation and tumor escape from the immune system.Oncol Rep. 2022 Jan;47(1):8. doi: 10.3892/or.2021.8219. Epub 2021 Nov 5. Oncol Rep. 2022. PMID: 34738625
-
Endothelial Cell Activation Is Regulated by Epidermal Growth Factor-like Domain 7 (Egfl7) during Inflammation.J Biol Chem. 2016 Nov 11;291(46):24017-24028. doi: 10.1074/jbc.M116.731331. Epub 2016 Sep 20. J Biol Chem. 2016. PMID: 27650497 Free PMC article.
-
EGFL7: Master regulator of cancer pathogenesis, angiogenesis and an emerging mediator of bone homeostasis.J Cell Physiol. 2018 Nov;233(11):8526-8537. doi: 10.1002/jcp.26792. Epub 2018 Jun 19. J Cell Physiol. 2018. PMID: 29923200 Review.
-
Anti-angiogenesis: making the tumor vulnerable to the immune system.Cancer Immunol Immunother. 2008 Oct;57(10):1553-8. doi: 10.1007/s00262-008-0524-3. Epub 2008 Apr 26. Cancer Immunol Immunother. 2008. PMID: 18438662 Free PMC article. Review.
Cited by
-
A Pan-Cancer Study of Epidermal Growth Factor-Like Domains 6/7/8 as Therapeutic Targets in Cancer.Front Genet. 2020 Dec 17;11:598743. doi: 10.3389/fgene.2020.598743. eCollection 2020. Front Genet. 2020. PMID: 33391349 Free PMC article.
-
MicroRNA-126 exerts antitumor functions in ovarian cancer by targeting EGFL7 and affecting epithelial-to-mesenchymal transition and ERK/MAPK signaling pathway.Oncol Lett. 2020 Aug;20(2):1327-1335. doi: 10.3892/ol.2020.11687. Epub 2020 May 29. Oncol Lett. 2020. PMID: 32724375 Free PMC article.
-
Novel Expression of EGFL7 in Osteosarcoma and Sensitivity to Cisplatin.Front Oncol. 2020 Feb 6;10:74. doi: 10.3389/fonc.2020.00074. eCollection 2020. Front Oncol. 2020. PMID: 32117731 Free PMC article.
-
EGFL7 reduces CNS inflammation in mouse.Nat Commun. 2018 Feb 26;9(1):819. doi: 10.1038/s41467-018-03186-z. Nat Commun. 2018. PMID: 29483510 Free PMC article.
-
Effect and Mechanism of EGFL7 Downregulation in Human Osteosarcoma Cells on the Biological Function of Co-cultured HUVEC.Balkan Med J. 2018 Mar 15;35(2):155-162. doi: 10.4274/balkanmedj.2017.0045. Epub 2018 Jan 24. Balkan Med J. 2018. PMID: 29363485 Free PMC article.
References
-
- Wu NZ, Klitzman B, Dodge R, Dewhirst MW. Diminished leukocyte-endothelium interaction in tumor microvessels. Cancer Res. 1992;52:4265–8. - PubMed
-
- Kuzu I, Bicknell R, Fletcher CD, Gatter KC. Expression of adhesion molecules on the endothelium of normal tissue vessels and vascular tumors. Lab Invest. 1993;69:322–8. - PubMed
-
- Dirkx AE, Oude Egbrink MC, Kujipers MJ, van der Neit ST, Heijnen VV, Bouta-ter Steege JC, et al. Tumor angiogenesis modulates leukocyte-vessel wall interactions in vivo by reducing endothelial adhesion molecule expression. Cancer Res. 2003;63:2322–9. - PubMed
LinkOut - more resources
Full Text Sources
